ChromaDex External Research Program (CERP™) Celebrates Over 250 Research Agreements With 235+ Researchers Around the World

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #MTA--ChromaDex Corp. (NASDAQ:CDXC) today celebrates over 250 material transfer agreements (MTAs) through the ChromaDex External Research Program (CERP™), featuring ChromaDex’s flagship ingredient Niagen® (patented nicotinamide riboside, or NR) and other proprietary ingredients. Over 235 independent scientists, doctors, and investigators across 182 institutions and 33 countries developed...

Click to view original post